← Back to Search

Other

High-Protein, Low-Glycemic Diet for Metabolic Syndrome (MAPS Trial)

N/A

Waitlist Available

Research Sponsored by University of Arkansas, Fayetteville

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18+ years

Be older than 18 years old

Must not have

Prescription medications related to heart disease or type 2 diabetes

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline at 16 weeks

Summary

This trial will test if regular potato consumption can improve cardiometabolic health in individuals with MetS.

Who is the study for?

Adults over 18 with Metabolic Syndrome, characterized by a combination of high triglycerides, low HDL cholesterol, high blood pressure, elevated fasting glucose levels or abdominal obesity. Participants should be from Northwest Arkansas and currently eating a diet high in glycemic load. Those on heart disease or diabetes medications, with needle phobia, food allergies or dietary restrictions like vegetarianism are excluded.

What is being tested?

The trial is testing the effects of a higher protein, low glycemic load diet that includes potatoes more than four times per week on individuals with Metabolic Syndrome to see if it improves their cardiometabolic health.

What are the potential side effects?

While not explicitly stated for this dietary intervention trial, potential side effects may include gastrointestinal changes such as bloating or gas due to increased fiber intake and possible changes in energy levels.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am taking medication for heart disease or type 2 diabetes.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline at 16 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline at 16 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 16 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Plasma glucose levels

Serum lipid levels

Secondary study objectives

Appetite

Dietary intake

Marker of appetite and sleep

+4 more

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Placebo Group

Group I: Higher Protein, Low Glycemic Load with PotatoesExperimental Treatment1 Intervention

Higher Protein, Low Glycemic Load with Potatoes (HPLG-P): low- to moderate- glycemic load meals containing white potatoes. Participants will consume low- to moderate-glycemic meals for 16 weeks and will need to consume at least 4 meals containing white potatoes.

Group II: Higher Protein, Low Glycemic Load with Processed PotatoesActive Control1 Intervention

Higher Protein, Low Glycemic Load with Processed Potatoes (HPLG-PP): low- to moderate- glycemic load meals containing processed white potato products. Participants will consume low- to moderate-glycemic meals for 16 weeks and will need to consume at least 4 meals containing white potatoes.

Group III: Higher Protein, Low Glycemic Load - ControlPlacebo Group1 Intervention

Higher Protein, Low Glycemic Load (HPLG-C): low- to moderate- glycemic load meals containing control carbohydrate (e.g. rice, pasta). Participants will consume low- to moderate-glycemic meals for 16 weeks and will need to consume at least 4 meals containing control carbohydrate sources.

0 / 2Eligibility criteria met